Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Further Success for Link Technologies in Asia

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Japanese company GeneDesign joins growing list of distributors.

Following its announcement to expand into the Far East last month, certified specialist oligonucleotide reagent manufacturer Link Technologies Ltd, has agreed another distribution contract in Asia with Japanese company GeneDesign, Inc..

The deal comes just a few weeks after the signing of Zirench Technology for distribution in China.

Link Technologies is ISO 9001:2008 certified and manufacture a comprehensive range of reagents for DNA, RNA and PNA synthesis and modifications including a custom service for tailored compounds in specialist applications.

GeneDesign, located in Osaka, Japan, will represent Link Technologies throughout Japan and will be exhibiting at the forthcoming AsiaTIDES meeting on oligonucleotide and peptide research, technology and product development on February 26-28 in Tokyo, Japan.

Speaking about the agreement, Hideaki Sato, General Manager, Technical Support and Marketing at GeneDesign, Inc. said “Our collaboration with Link Technologies supports our goal of contributing to human welfare and health through nucleic acid technology development. We are delighted to be working with Link Technologies to increase the presence and usage of their high quality, reliable oligo precursor products in Japan. We invite people to visit us at the AsiaTIDES meeting to discover in detail the many benefits of these new offerings.”

Dr John Bremner, CEO at Link Technologies added “By working with GeneDesign we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan. This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our on-going strategic plans for development and growth. GeneDesign is a company that values the importance of this and we look forward to working with them.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Link Technologies Announces Partnership with American International Chemical
AIC to distribute Link’s specialist oligonucleotide modifiers in North America.
Wednesday, May 23, 2012
Link Technologies Secures Exclusive License for Ultra Sensitive Diagnostic Probes
Deal marks the start of ongoing collaboration between Link and The University of Manchester.
Tuesday, December 01, 2009
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Monday, May 18, 2009
Scientific News
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!